The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Independent verification · continued

Publishing an inconvenient result: a case study — the long version posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

OO
orbitrap_olaTL3Mass spectrometrist8 Nov 2025#31
v.milanovi, post #13: I have been on both sides of the Publishing an inconvenient result argument in this category within eighteen months, which should tell you how strong the evidence for either side is. Go to post

Publishing an inconvenient result would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

14 likes in reply to #13 9mo
PM
p.mwangiTL29 Nov 2025#32
j.teixeira, post #20: What I would check first on Publishing an inconvenient result is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph. Go to post

Adding a null result on Publishing an inconvenient result. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.

29 likes in reply to #20 9mo
PW
PharmNotes_WhitfieldTL4Pharmacist10 Nov 2025#33

Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.

It is worth stating the boring hypothesis before the interesting one.

0 likes 9mo
NK
n.kuuselaTL211 Nov 2025 · edited#34

Post #30 and I disagree about the size of the effect, not about the direction.

What I would tell a new member reading about Publishing an inconvenient result for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

2 likes 9mo
JW
journalclub_wrenTL3Regular12 Nov 2025#35

Narrowing post #32, because the general version has more than one answer.

Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago.

Adding a source would improve this post and I do not have one to hand.

20 likes 8mo
YA
y.asanteTL213 Nov 2025#36
DS
dr_seongTL3Physician14 Nov 2025#37

Appreciated. The plain phrasing does more work here than a longer post would.

0 likes 8mo
RF
ro.friskTL215 Nov 2025#38

Asking the supplier before publishing a discrepancy is the convention here. Most discrepancies are explained by handling or method and asking costs a day.

That is a description of practice, not a recommendation of it.

5 likes 8mo
NN
n.nybergTL216 Nov 2025#39

On Publishing an inconvenient result, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

28 likes 8mo
TP
t.pereiraTL217 Nov 2025#40
PharmNotes_Whitfield, post #33: Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern. It is worth stating the boring hypothesis before the interesting one. Go to post

Answering the question post #38 raises rather than the one it answers.

Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.

Small point, but it is the one that usually catches people.

0 likes in reply to #33 8mo
MB
m.balogunTL218 Nov 2025#41

Coming back to post #39, because the follow-up matters more than the original answer.

The claim about Publishing an inconvenient result upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

7 likes 8mo
UC
unit_conversionTL3Regular19 Nov 2025#42

Post #39 is right about the mechanism and I think understates the practical bit.

It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.

I have kept the units in throughout, for the obvious reason.

1 like 8mo
RV
r.vukovicTL220 Nov 2025#43
TP
tracked_parcelTL2Regular21 Nov 2025#44
e.nilsen, post #28: A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Filing this under things that are true until someone shows me otherwise. Go to post

Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.

17 likes in reply to #28 8mo
AV
ai.vukovicTL222 Nov 2025#45

I had written a reply contradicting post #44 and deleted it. Here is what survived.

Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.

The interesting part of this is the exception, and I do not understand the exception.

11 likes 8mo
ER
eire_readerTL2Regional · IE23 Nov 2025#46

Publishing an inconvenient result: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

3 likes 8mo
FH
f.haddadTL224 Nov 2025#47
ai.vukovic, post #45: I had written a reply contradicting post #44 and deleted it. Here is what survived. Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. The interesting part of this is the exception, and I do not understand the exception. Go to post

Right — I had this wrong and I am glad to have read it before it mattered.

0 likes in reply to #45 8mo
PN
p.novotnyTL2Regular24 Nov 2025#48
y.asante, post #36: Publishing an inconvenient result has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time. Go to post

Picking up post #46: that is the part I would want checked first.

My understanding of Publishing an inconvenient result is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

24 likes in reply to #36 8mo
ZO
z.okonkwoTL225 Nov 2025#49

Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.

17 likes 8mo
PI
p.iyer_pharmdTL3Pharmacist26 Nov 2025#50

That is a fair summary of where the discussion has got to.

6 likes 8mo
LS
l.solbergTL227 Nov 2025#51

I have no financial interest in anything named in this thread and I want to say so before I comment on Publishing an inconvenient result, because it is the sort of subject where it matters.

12 likes 8mo
EV
e.verhoevenTL228 Nov 2025#52
journalclub_wren, post #35: Narrowing post #32, because the general version has more than one answer. Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago. Adding a source would improve this post and I do not have one to hand. Go to post

Practical answer on Publishing an inconvenient result, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not.

26 likes in reply to #35 8mo
RL
r.laurentTL229 Nov 2025#53

Bookmarking this. I will come back when I have something worth adding.

0 likes 8mo
MP
mira.patelTL4 Admin30 Nov 2025#54

Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago.

4 likes 8mo
CB
c.boatengTL21 Dec 2025#55

The failure mode on Publishing an inconvenient result is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

8 likes 8mo
OB
owen.bradyTL4 Moderator2 Dec 2025#56
r.vukovic, post #43: Publishing an inconvenient result has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet. Go to post

I had written a reply contradicting post #52 and deleted it. Here is what survived.

Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and selective reporting. The extra effort is worth it.

Written in the hope of being told what I have missed.

19 likes in reply to #43 8mo
SD
s.dialloTL23 Dec 2025#57
owen.brady, post #56: I had written a reply contradicting post #52 and deleted it. Here is what survived. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and selective reporting. The extra effort is worth it. Written in the hope of being told what I… Go to post

Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.

0 likes in reply to #56 8mo
PP
peak_purityTL3Analytical chemist4 Dec 2025#58

One more thing on Publishing an inconvenient result that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

2 likes 8mo
O
OstrowskiTL2Member4 Dec 2025#59

Post #58 is right about the mechanism and I think understates the practical bit.

Asking the supplier before publishing a discrepancy is the convention here. Most discrepancies are explained by handling or method and asking costs a day.

The short answer was in the first line; everything after is the working.

25 likes 8mo
JS
j.silvaTL25 Dec 2025#60

Coming back to post #56, because the follow-up matters more than the original answer.

What I can speak to on Publishing an inconvenient result is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.

0 likes 8mo